INSIGHTS ON DRUG DEVELOPMENT
-
Complete Your Journey To Therapeutic Success
Explore integrated workflows for peptide identification, impurity analysis, sequence confirmation, and characterization, supported by advanced technology and expert guidance to improve productivity.
-
Screening For Amorphous Drug Substance
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
Ushering In A New Era Of Human-Relevant Drug Discovery
With most drug candidates failing before approval, researchers need better ways to predict human responses. Gain insight into how advances in human-relevant modeling are helping improve decisions.
-
Facilitate Handling Of Bulk Powders With Dry Granulation
Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.
-
Cross-Site Work Within Cambrex's Network7/24/2026
Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising6/9/2026
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
Engineering The Future Of Lipsomal Drug Delivery5/14/2025
Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.
-
Quality Assurance In IVT RNA Vaccine Development Using Electrophoresis2/20/2025
Discover advanced solutions for IVT RNA synthesis, focusing on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development processes.
-
Addressing Raw Material Handling Challenges By Dry Granulation8/12/2025
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
DRUG DEVELOPMENT SOLUTIONS
-
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.
-
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Explore the design services offered by the Gibco Media by Design team including cell line development, media and feed panel evaluations, bioproduction analytics and more.